Exact Mass: 329.1865

Exact Mass Matches: 329.1865

Found 77 metabolites which its exact mass value is equals to given mass value 329.1865, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

EUROPINE

9-Lasiocarpylheliotridine

C16H27NO6 (329.1838)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2321

   

Trifenmorph

4-Tritylmorpholine

C23H23NO (329.178)


   

Non-5-enedioylcarnitine

3-[(8-carboxyoct-5-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C16H27NO6 (329.1838)


Non-5-enedioylcarnitine is an acylcarnitine. More specifically, it is an non-5-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. non-5-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine non-5-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Non-6-enedioylcarnitine

3-[(8-carboxyoct-6-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C16H27NO6 (329.1838)


Non-6-enedioylcarnitine is an acylcarnitine. More specifically, it is an non-6-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. non-6-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine non-6-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E)-Non-2-enedioylcarnitine

3-[(8-carboxyoct-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C16H27NO6 (329.1838)


(2E)-non-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an (2E)-non-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-non-2-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E)-non-2-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Gabapentin enacarbil

2-(1-{[({1-[(2-methylpropanoyl)oxy]ethoxy}carbonyl)amino]methyl}cyclohexyl)acetic acid

C16H27NO6 (329.1838)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

   

Sunepitron

1-[(2-Pyrimidin-2-yl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-7-yl)methyl]pyrrolidine-2,5-dione

C17H23N5O2 (329.1852)


   

Heliotrine N-oxide

Heliotrine N-oxide

C16H27NO6 (329.1838)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2274

   

Ilamine N-oxide

Ilamine N-oxide

C16H27NO6 (329.1838)


   
   

Fortimicin AH|Fortimicin AI

Fortimicin AH|Fortimicin AI

C15H27N3O5 (329.1951)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

butyl prop-2-enoate,N-(hydroxymethyl)prop-2-enamide,methyl 2-methylprop-2-enoate

butyl prop-2-enoate,N-(hydroxymethyl)prop-2-enamide,methyl 2-methylprop-2-enoate

C16H27NO6 (329.1838)


   

Boc-L-glutamic acid 5-cyclohexyl ester

Boc-L-glutamic acid 5-cyclohexyl ester

C16H27NO6 (329.1838)


   

1-tert-butyl 4,4-diethyl piperidine-1,4,4-tricarboxylate

1-tert-butyl 4,4-diethyl piperidine-1,4,4-tricarboxylate

C16H27NO6 (329.1838)


   

Butriptyline hydrochloride

Butriptyline hydrochloride

C21H28ClN (329.191)


   

(S)-5-METHOXY-N-PROPYL-N-(2-(THIOPHEN-2-YL)ETHYL)-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE

(S)-5-METHOXY-N-PROPYL-N-(2-(THIOPHEN-2-YL)ETHYL)-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE

C20H27NOS (329.1813)


   

(2E)-1-(4-BROMOPHENYL)-3-PHENYLPROP-2-EN-1-ONE

(2E)-1-(4-BROMOPHENYL)-3-PHENYLPROP-2-EN-1-ONE

C23H23NO (329.178)


   

(S)-2 Azido-3-(3-indolyl)propionic acid cyclohexylamMonium salt

(S)-2 Azido-3-(3-indolyl)propionic acid cyclohexylamMonium salt

C17H23N5O2 (329.1852)


   

2-[3-(1-carbamoyl-1-methylethyl)-5-[1,2,4]triazol-1-ylmethylphenyl]-isobutyramide

2-[3-(1-carbamoyl-1-methylethyl)-5-[1,2,4]triazol-1-ylmethylphenyl]-isobutyramide

C17H23N5O2 (329.1852)


   

4-N-BOC-AMINOMETHYL-1-N-BOC-PYRROLIDIN-3-ONE OXIME

4-N-BOC-AMINOMETHYL-1-N-BOC-PYRROLIDIN-3-ONE OXIME

C15H27N3O5 (329.1951)


   

2-(TETRAHYDRO-2H-PYRAN-4-YLOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZONITRILE

2-(TETRAHYDRO-2H-PYRAN-4-YLOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZONITRILE

C18H24BNO4 (329.1798)


   

6,7-dimethoxy-2-(4-prop-2-enylpiperazin-1-yl)quinazolin-4-amine

6,7-dimethoxy-2-(4-prop-2-enylpiperazin-1-yl)quinazolin-4-amine

C17H23N5O2 (329.1852)


   

2-Methyl-4-[2-(4-phenylcyclohexylidene)hydrazin-1-yl]quinoline

2-Methyl-4-[2-(4-phenylcyclohexylidene)hydrazin-1-yl]quinoline

C22H23N3 (329.1892)


   

New fuchsin free base

New fuchsin free base

C22H23N3 (329.1892)


   

L-Leucyl-L-prolyl-L-threonine

L-Leucyl-L-prolyl-L-threonine

C15H27N3O5 (329.1951)


   
   

Gabapentin enacarbil

Gabapentin enacarbil

C16H27NO6 (329.1838)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

   

Non-5-enedioylcarnitine

Non-5-enedioylcarnitine

C16H27NO6 (329.1838)


   

Non-6-enedioylcarnitine

Non-6-enedioylcarnitine

C16H27NO6 (329.1838)


   

(2E)-Non-2-enedioylcarnitine

(2E)-Non-2-enedioylcarnitine

C16H27NO6 (329.1838)


   

[3-[(2-Methylphenyl)methyl]-1-[(5-methyl-2-thiophenyl)methyl]-3-piperidinyl]methanol

[3-[(2-Methylphenyl)methyl]-1-[(5-methyl-2-thiophenyl)methyl]-3-piperidinyl]methanol

C20H27NOS (329.1813)


   

N-[2-(4-tert-butylphenoxy)ethyl]-2-(4-fluorophenyl)acetamide

N-[2-(4-tert-butylphenoxy)ethyl]-2-(4-fluorophenyl)acetamide

C20H24FNO2 (329.1791)


   

1-methyl-N,N-bis(trimethylsilyl)-5-[(trimethylsilyl)oxy]imidazol-2-amine

1-methyl-N,N-bis(trimethylsilyl)-5-[(trimethylsilyl)oxy]imidazol-2-amine

C13H31N3OSi3 (329.1775)


   
   
   
   
   
   
   
   
   
   
   
   

(2E)-11-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]undec-2-enoate

(2E)-11-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]undec-2-enoate

C17H29O6- (329.1964)


   

(E,10R)-10-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyundec-2-enoate

(E,10R)-10-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyundec-2-enoate

C17H29O6- (329.1964)


   

N-Acetyl-alanyl-leucyl-alanine methylester

N-Acetyl-alanyl-leucyl-alanine methylester

C15H27N3O5 (329.1951)


   

oscr#17(1-)

oscr#17(1-)

C17H29O6 (329.1964)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#17, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

ascr#17(1-)

ascr#17(1-)

C17H29O6 (329.1964)


Conjugate base of ascr#17

   
   
   

(2r,5e)-2-[(4r)-1-(2,4-dihydroxybutyl)-2-iminoimidazolidin-4-yl]-7-hydroxy-6-methylhept-5-enoic acid

(2r,5e)-2-[(4r)-1-(2,4-dihydroxybutyl)-2-iminoimidazolidin-4-yl]-7-hydroxy-6-methylhept-5-enoic acid

C15H27N3O5 (329.1951)


   

(1s,4r,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

(1s,4r,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

C16H27NO6 (329.1838)


   

(7as)-1-({[(2r)-2,3-dihydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

(7as)-1-({[(2r)-2,3-dihydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

C16H27NO6 (329.1838)


   

(1s,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

(1s,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

C16H27NO6 (329.1838)


   

(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 2,3-dihydroxy-2-(1-methoxyethyl)-3-methylbutanoate

(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 2,3-dihydroxy-2-(1-methoxyethyl)-3-methylbutanoate

C16H27NO6 (329.1838)


   

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r)-2,3-dihydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoate

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r)-2,3-dihydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoate

C16H27NO6 (329.1838)


   

(1s,7as)-1-hydroxy-7-{[(2-hydroxy-2-isopropyl-3-methoxybutanoyl)oxy]methyl}-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

(1s,7as)-1-hydroxy-7-{[(2-hydroxy-2-isopropyl-3-methoxybutanoyl)oxy]methyl}-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

C16H27NO6 (329.1838)


   

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2,3-dihydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoate

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2,3-dihydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoate

C16H27NO6 (329.1838)